Avinger regains compliance with nasdaq listing requirements

Redwood city, ca / accesswire / march 29, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced it has regained compliance with nasdaq listing requirements. in a letter dated march 29, 2022, nasdaq informed the company that it has achieved compliance with the minimum bid price rule required for continued listing on the nasdaq capital market.
AVGR Ratings Summary
AVGR Quant Ranking